Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-16-000027 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.20% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.70% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-6.72% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.85% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
38.43% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
12.29% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.60% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.41% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Mar 31, 2019 8/8 normalized Level 3 Jun 30, 2019 7/7 normalized Level 3 Sep 30, 2019 8/8 normalized Level 3 Dec 31, 2019 8/8 normalized Level 3 Mar 31, 2020 8/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Dec 31, 2020 8/8 normalized Level 3 Mar 31, 2021 8/8 normalized Level 3 Jun 30, 2021 8/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 2.33%
Current 3.20%
Delta 0.87% Cash Generation Decreased
Previous 15.19%
Current 12.70%
Delta -2.49% Growth Decreased
Previous -6.33%
Current -6.72%
Delta -0.38% Inventory Pressure Decreased
Previous 52.88%
Current 11.85%
Delta -41.03% Margin Decreased
Previous 38.91%
Current 38.43%
Delta -0.48% Profitability Decreased
Previous 13.30%
Current 12.29%
Delta -1.01% R And D Intensity Increased
Previous 2.55%
Current 2.60%
Delta 0.05% Sbc Intensity Increased
Previous 0.33%
Current 0.41%
Delta 0.08% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.